468 related articles for article (PubMed ID: 33669846)
1. Human TRIM5α: Autophagy Connects Cell-Intrinsic HIV-1 Restriction and Innate Immune Sensor Functioning.
Cloherty APM; Rader AG; Compeer B; Ribeiro CMS
Viruses; 2021 Feb; 13(2):. PubMed ID: 33669846
[TBL] [Abstract][Full Text] [Related]
2. Mutational resilience of antiviral restriction favors primate TRIM5α in host-virus evolutionary arms races.
Tenthorey JL; Young C; Sodeinde A; Emerman M; Malik HS
Elife; 2020 Sep; 9():. PubMed ID: 32930662
[TBL] [Abstract][Full Text] [Related]
3. High Levels of TRIM5α Are Associated with Xenophagy in HIV-1-Infected Long-Term Nonprogressors.
Ciccosanti F; Corazzari M; Casetti R; Amendola A; Collalto D; Refolo G; Vergori A; Taibi C; D'Offizi G; Antinori A; Agrati C; Fimia GM; Ippolito G; Piacentini M; Nardacci R
Cells; 2021 May; 10(5):. PubMed ID: 34069225
[TBL] [Abstract][Full Text] [Related]
4. Receptor usage dictates HIV-1 restriction by human TRIM5α in dendritic cell subsets.
Ribeiro CM; Sarrami-Forooshani R; Setiawan LC; Zijlstra-Willems EM; van Hamme JL; Tigchelaar W; van der Wel NN; Kootstra NA; Gringhuis SI; Geijtenbeek TB
Nature; 2016 Dec; 540(7633):448-452. PubMed ID: 27919079
[TBL] [Abstract][Full Text] [Related]
5. K63-Linked Ubiquitin Is Required for Restriction of HIV-1 Reverse Transcription and Capsid Destabilization by Rhesus TRIM5α.
Imam S; Kömürlü S; Mattick J; Selyutina A; Talley S; Eddins A; Diaz-Griffero F; Campbell EM
J Virol; 2019 Jul; 93(14):. PubMed ID: 31068426
[TBL] [Abstract][Full Text] [Related]
6. From Capsids to Complexes: Expanding the Role of TRIM5α in the Restriction of Divergent RNA Viruses and Elements.
Rose KM; Spada SJ; Broeckel R; McNally KL; Hirsch VM; Best SM; Bouamr F
Viruses; 2021 Mar; 13(3):. PubMed ID: 33801908
[TBL] [Abstract][Full Text] [Related]
7. Editing of the TRIM5 Gene Decreases the Permissiveness of Human T Lymphocytic Cells to HIV-1.
Désaulniers K; Ortiz L; Dufour C; Claudel A; Plourde MB; Merindol N; Berthoux L
Viruses; 2020 Dec; 13(1):. PubMed ID: 33375604
[TBL] [Abstract][Full Text] [Related]
8. Lentiviral gene therapy against human immunodeficiency virus type 1, using a novel human TRIM21-cyclophilin A restriction factor.
Chan E; Schaller T; Eddaoudi A; Zhan H; Tan CP; Jacobsen M; Thrasher AJ; Towers GJ; Qasim W
Hum Gene Ther; 2012 Nov; 23(11):1176-85. PubMed ID: 22909012
[TBL] [Abstract][Full Text] [Related]
9. Immunoproteasome activation enables human TRIM5α restriction of HIV-1.
Jimenez-Guardeño JM; Apolonia L; Betancor G; Malim MH
Nat Microbiol; 2019 Jun; 4(6):933-940. PubMed ID: 30886358
[TBL] [Abstract][Full Text] [Related]
10. TRIM5α and TRIM22 are differentially regulated according to HIV-1 infection phase and compartment.
Singh R; Patel V; Mureithi MW; Naranbhai V; Ramsuran D; Tulsi S; Hiramen K; Werner L; Mlisana K; Altfeld M; Luban J; Kasprowicz V; Dheda K; Abdool Karim SS; Ndung'u T
J Virol; 2014 Apr; 88(8):4291-303. PubMed ID: 24478420
[TBL] [Abstract][Full Text] [Related]
11. A helical LC3-interacting region mediates the interaction between the retroviral restriction factor Trim5α and mammalian autophagy-related ATG8 proteins.
Keown JR; Black MM; Ferron A; Yap M; Barnett MJ; Pearce FG; Stoye JP; Goldstone DC
J Biol Chem; 2018 Nov; 293(47):18378-18386. PubMed ID: 30282803
[TBL] [Abstract][Full Text] [Related]
12. Cyclophilin A protects HIV-1 from restriction by human TRIM5α.
Kim K; Dauphin A; Komurlu S; McCauley SM; Yurkovetskiy L; Carbone C; Diehl WE; Strambio-De-Castillia C; Campbell EM; Luban J
Nat Microbiol; 2019 Dec; 4(12):2044-2051. PubMed ID: 31636416
[TBL] [Abstract][Full Text] [Related]
13. A novel envelope mediated post entry restriction of murine leukaemia virus in human cells is Ref1/TRIM5α independent.
Oliveira NM; Trikha R; McKnight Á
Retrovirology; 2010 Oct; 7():81. PubMed ID: 20929586
[TBL] [Abstract][Full Text] [Related]
14. A non-canonical role for the autophagy machinery in anti-retroviral signaling mediated by TRIM5α.
Saha B; Chisholm D; Kell AM; Mandell MA
PLoS Pathog; 2020 Oct; 16(10):e1009017. PubMed ID: 33052966
[TBL] [Abstract][Full Text] [Related]
15. The control of viral infection by tripartite motif proteins and cyclophilin A.
Towers GJ
Retrovirology; 2007 Jun; 4():40. PubMed ID: 17565686
[TBL] [Abstract][Full Text] [Related]
16. TRIM34 restricts HIV-1 and SIV capsids in a TRIM5α-dependent manner.
Ohainle M; Kim K; Komurlu Keceli S; Felton A; Campbell E; Luban J; Emerman M
PLoS Pathog; 2020 Apr; 16(4):e1008507. PubMed ID: 32282853
[TBL] [Abstract][Full Text] [Related]
17. Variations in Trim5α and Cyclophilin A genes among HIV-1 elite controllers and non controllers in Uganda: a laboratory-based cross-sectional study.
Amanya SB; Nyiro B; Waswa F; Obura B; Nakaziba R; Nabulime E; Katabazi AF; Nabatanzi R; Bayiyana A; Mboowa G; Kayongo A; Wayengera M; Sande OJ
Retrovirology; 2020 Jul; 17(1):19. PubMed ID: 32631377
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 with gag processing defects activates cGAS sensing.
Sumner RP; Blest H; Lin M; Maluquer de Motes C; Towers GJ
Retrovirology; 2024 May; 21(1):10. PubMed ID: 38778414
[TBL] [Abstract][Full Text] [Related]
19. Lack of endogenous TRIM5alpha-mediated restriction in rhesus macaque dendritic cells.
Arhel NJ; Nisole S; Carthagena L; Coutant F; Souque P; Brussel A; Estaquier J; Charneau P
Blood; 2008 Nov; 112(9):3772-6. PubMed ID: 18703703
[TBL] [Abstract][Full Text] [Related]
20. [Retrovirus Restriction Factor TRIM5α: The Mechanism of Action and Prospects for Use in Gene Therapy of HIV Infection].
Glazkova DV; Urusov FA; Bogoslovskaya EV; Shipulin GA
Mol Biol (Mosk); 2020; 54(5):707-717. PubMed ID: 33009785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
